# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056077
Filing Date
2024-05-09
Accepted
2024-05-08 19:13:29
Documents
66
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acad-20240331.htm iXBRL | 10-Q | 1590047
2 | EX-10.1 | acad-ex10_1.htm | EX-10.1 | 66509
3 | EX-10.2 | acad-ex10_2.htm | EX-10.2 | 92916
4 | EX-10.3 | acad-ex10_3.htm | EX-10.3 | 174708
5 | EX-31.1 | acad-ex31_1.htm | EX-31.1 | 10617
6 | EX-31.2 | acad-ex31_2.htm | EX-31.2 | 10767
7 | EX-32.1 | acad-ex32_1.htm | EX-32.1 | 7487
8 | EX-32.2 | acad-ex32_2.htm | EX-32.2 | 7545
9 | GRAPHIC | img91857729_0.jpg | GRAPHIC | 278460
| Complete submission text file | 0000950170-24-056077.txt |  | 7646097

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | acad-20240331.xsd | EX-101.SCH | 913316
69 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-20240331_htm.xml | XML | 1237153

Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 24928007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)